Beta Testing Coming Soon
Smarter Biomedical Discovery
Rejuve Biotech is building an AI-driven research platform that accelerates the discovery of therapies for aging and age-related diseases.
Problems in Biomedicine
Drug discovery is long, expensive and siloed
Aging drives the majority of chronic diseases—from Alzheimer’s to cardiovascular decline, but only a fraction of promising ideas ever reach patients.
Advanced AI Solution
Meet Mozi, your
AI co-scientist
Rejuve Biotech’s AI biomedical research platform builds structured knowledge, generates testable hypotheses, and validates them with living systems.
Data Ingestion
The platform unifies genetic, clinical, and preclinical datasets into a structured knowledge graph.
Hypothesis Generation
Neural-symbolic AI produces candidate links between biological pathways and potential treatments.
Predictive Modeling
AI evaluates interventions against known hallmarks of aging to prioritize the most promising.
Validation
Findings are tested against Methuselah Fly outcomes and human health data from the Rejuve Network.
FAQ
Frequently asked questions
What type(s) of AI does Rejuve Biotech use?
Can the tool identify novel biomarkers, or does it mainly validate known ones?
Is the AI explainable — can one trace how a given prediction or hypothesis was derived?
Is there a collaborative workspace where researchers can annotate, share, or review AI outputs?
Early Access
Want to be a part of our Beta testing? Contact our team!
Rejuve Biotech builds an AI biomedical research platform that discovers, validates, and delivers interventions to slow or reverse aging — making longer, healthier lives possible.